+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dalteparin"

Heparin Global Market Report 2024 - Product Thumbnail Image

Heparin Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Dalteparin is a low molecular weight heparin (LMWH) anticoagulant used to prevent and treat thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). Dalteparin is administered subcutaneously and is available in a variety of dosage forms. Dalteparin is a widely used anticoagulant in the cardiovascular drugs market. It is used to prevent and treat thromboembolic disorders, reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and to reduce the risk of recurrent myocardial infarction. It is also used to reduce the risk of death and recurrent myocardial infarction in patients with acute coronary syndrome. Some companies in the Dalteparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more